FDA Investigator Jose Velez

Jose Velez has conducted inspections on 76 sites in 6 countries as of 25 Jul 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
76
Last Inspection Date:
25 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, Puerto Rico, Korea (Republic of), China, India, Colombia
FDA Investigators that have inspected at least one site in common with Jose Velez:
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Albert A Salvador, Alonso, Amber G Wardwell, An T Vu, Ana M Rivera, Andrea George, PhD, Angelica M Hernandez, Ann L Demarco, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Arwa S El Hagrasy, Ashley N Queen, PhD, Binh T Nguyen, Brandon C Heitmeier, Brenda Rivera, Brenda S Zimmer, PhD, Calvin B Koerner, Carlos A Medina, Cassandra L Abellard, CDR Ileana Barreto Pettit, Chelsea N Sealey, Cheryl A Clausen, Christie A Soto, Christina Capacci Daniel, PhD, Christopher Downey, PhD, Christopher T Peters, Colleen Thomas, PhD, Concepcion Cruz, Jr, Damaris Y Hernandez, Daniel J Roberts, Dayna I Martinez, Dennis Cantellops Paite, Dewayne E Whitlock, Diane L Raccasi, Dianiris C Ayala, Dipesh K Shah, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Christner, Douglas A Campbell, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Eddie A Santini, Edward H Maticka, Edwin Martinez, Edwin Ortega, Eileen A Liu, Eliezar Ramos, Enrique Galan, Erika E Englund, PhD, Erika V Butler, Eva I Merced Medina, Felix Maldonado, Frances L Dejesus, Frederick L Fricke, Gabriel E Muniz, Garcial, Gayle S Lawson, German Rivera, Gregory Price, Harshal J Desai, Hector Espinet, Hector Jcolon Torres, Iraida Ortiz, Israel Santiago, OCM, Ivis L Negron, Ivonne A Vicente, J'maica J Hunter, Jaime E Pares, Jason F Chancey, Javier O Vega, Jeffrey P Raimondi, Jennifer A Quinones, Jennifer L Bridgewater, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jerri Baker, Jessica L Pressley, Jessica P Mcalister, Joan M Cantellops Figueroa, Joann Walters Salvatierra, Joanne E King, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Perez Soto, Jose R Lopez, Jose Rflores Veguilla, Joshua J Silvestri, Julianne C Mccullough, Justin A Boyd, Karen A Wolnik, Karen M Rodriguez, Karl D Hezel, Katherine V Serrano, Kayla V Sprague, Kejun Cheng, Kevin A Gonzalez, Kham Phommachanh, Laiza V Garcia, Lakshmi Narasimhan, PhD, Larry K Hampton, Laura E Garcia, Laura Fontan, MS, Laurimer Kuilan Torres, LCDR Michael H Tollon, Libia M Lugo, Lillian Mcolon Mcknight, Lisa M Lopez, Lizaida E Rodriguez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Kimberly M Hull, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Martinez Larracuente, Luis Soto Lopez, Margarita Santiago, Maria A Ruttell, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Marilyn Santiago, Marion Michaelis, Marisol Faberlle, Marlene Rodriguez Colon, Mary A Millner, Matthew B Casale, Matthew B Thomaston, Maxwell Van Tassell, PhD, Medina, Melanie M Walker, Mendoza, Michael A Charles, Michael Levy, Michael Shanks, MS, Michael T Cyrus, Michelle K Cockrell, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Miguel Hernandez Sanchez, Mihaly S Ligmond, Milva E Melendez Perales, Min Tang, Minerva Rogers, Mizanne E Lewis, Moraima Jramos Valle, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nakesha J Jackson, Nancy Rosado, Naveen B Kanthamneni, Neal L Adams, Neisa M Alonso, Nicholas Obiri, PhD, Nicole E Knowlton, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul L Bellamy, Paul Z Balcer, Paula A Trost, Paula M Laplant, Philippa Hillyer, Pratik S Upadhyay, DDC, Rafael E Arroyo, Rafael E Cruz, Rafael Nevarez Nieves, Raihan A Chowdhury, Rakhi B Shah, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regan T Harp, Regina T Brown, Richard E Needham, Riley C Myers, PhD, Robert Darius, Robert Sharpnack, Salvatore N Randazzo, Samantha E Cleek, Samina S Khan, Sandra A Hughes, Santos E Camara, Saundrea A Munroe, Sharmista Chatterjee, Sharon K Thoma, PharmD, Sixto M Mercado Rios, Sonia M Monges, Sony Mathews, Stephanie D Crockett, Steven A Brettler, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Steven P Donald, Susan T Hadman, Suzanne N Vallez, Teresa I Navas, Terri L Dodds, Thomas J Arista, Tiara Nbrown Crosen, Timothy Wadkin, PhD, Victor S Pacheco, Vilmary Negron Rodriguez, Vivin George, Walden H Lee, Wanda J Torres, Wayne T Smith, Wendy G Tan, PhD, Xiaokuang Lai, PhD, Yeissa Chabrier Rosello, Yifan Wang, Yvins Dezan, Zachary L Stamm, Zhong Li, PhD, Zhongren Wu

Jose Velez's Documents

Publish Date Document Type Title
October, 2018 EIR Baxter Healthcare Corporation - EIR, 2018-10-24
October, 2014 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2014-10-24
July, 2021 FDA 483 Response Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483R, 2021-08-02
February, 2016 FDA 483 Agropharma Laboratories Inc. - Form 483, 2016-02-12
March, 2018 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2018-03-28
July, 2021 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2021-07-12
January, 2016 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2016-01-22
March, 2016 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2016-03-23
October, 2015 FDA 483 Knoll LLC - Form 483, 2015-10-23
May, 2014 FDA 483 AbbVie Ltd - Form 483, 2014-05-20
August, 2019 FDA 483 QOL Medical, LLC - Form 483, 2019-08-30
August, 2018 FDA 483 PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC - Form 483, 2018-08-17
August, 2015 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2015-08-14
October, 2016 FDA 483 Baxter Healthcare Corporation - Form 483, 2016-10-03
March, 2020 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2020-03-10
May, 2018 FDA 483 HILL DERMACEUTICALS, INC. - Form 483, 2018-05-18
February, 2023 FDA 483 Lilly del Caribe, Inc. - Form 483, 2023-02-17
July, 2021 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2021-07-12
September, 2018 FDA 483 Agropharma Laboratories Inc. - Form 483, 2018-09-14
December, 2019 FDA 483 Steriscience Specialties Private Limited - Form 483, 2019-12-20
November, 2017 FDA 483 Dextrum Laboratories Inc. - Form 483, 2017-11-17
May, 2016 FDA 483 Grafor, Inc. - Form 483, 2016-05-06
May, 2023 FDA 483 Amneal Pharmaceuticals Private Limited - Form 483, 2023-05-02
December, 2019 FDA 483 Steril-Gene Life Sciences Private Limited - Form 483, 2019-12-10
March, 2014 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2014-03-11
March, 2021 FDA 483 PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC - Form 483, 2021-03-17
January, 2018 EIR Viatris Pharmaceuticals LLC - EIR, 2018-01-26
May, 2019 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2019-05-03
March, 2023 FDA 483 Janssen Ortho LLC - Form 483, 2023-03-28
March, 2014 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2014-03-11
August, 2016 FDA 483 Destileria Serralles, Inc. - Form 483, 2016-08-09
August, 2015 EIR Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - EIR, 2015-08-14
October, 2018 FDA 483 Baxter Healthcare Corporation - Form 483, 2018-10-24
October, 2019 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2019-10-15
January, 2023 FDA 483 Galephar Pharmaceutical Research Inc. - Form 483, 2023-01-20
June, 2018 FDA 483 CMIC CMO Korea Co., Ltd. - Form 483, 2018-06-15
January, 2018 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2018-01-26
June, 2019 FDA 483 CORERX, INC. - Form 483, 2019-06-21
April, 2019 FDA 483 Goodwin Biotechnology, Inc - Form 483, 2019-04-10
August, 2019 EIR QOL Medical, LLC - EIR, 2019-08-30
July, 2023 FDA 483 Response Amgen Manufacturing Limited LLC - Form 483R, 2023-07-19
July, 2023 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2023-07-05
November, 2022 FDA 483 B Braun Medical Inc - Form 483, 2022-11-22
March, 2014 EIR Viatris Pharmaceuticals LLC - EIR, 2014-03-11
March, 2019 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2019-03-06
May, 2014 EIR AbbVie Ltd - EIR, 2014-05-20
July, 2023 FDA 483 Aeropres Corp - Form 483, 2023-07-27

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more